OptimizeRx Corp (NASDAQ: OPRX) on Friday, soared 34.74% from the previous trading day, before settling in for the closing price of $12.84. Within the past 52 weeks, OPRX’s price has moved between $3.78 and $15.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -36.18% over the past five years. The company achieved an average annual earnings per share of 93.07%. With a float of $16.75 million, this company’s outstanding shares have now reached $18.56 million.
Let’s look at the performance matrix of the company that is accounted for 129 employees. In terms of profitability, gross margin is 62.97%, operating margin of -11.44%, and the pretax margin is -17.08%.
OptimizeRx Corp (OPRX) Insider and Institutional Ownership
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of OptimizeRx Corp is 9.41%, while institutional ownership is 66.71%. The most recent insider transaction that took place on Mar 14 ’25, was worth 2,443,761. In this transaction Director of this company bought 321,408 shares at a rate of $7.60, taking the stock ownership to the 389,452 shares. Before that another transaction happened on Dec 12 ’24, when Company’s CEO bought 20,000 for $5.01, making the entire transaction worth $100,220. This insider now owns 601,253 shares in total.
OptimizeRx Corp (OPRX) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.12 earnings per share (EPS) for the period topping the consensus outlook (set at 0.06) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.07% per share during the next fiscal year.
OptimizeRx Corp (NASDAQ: OPRX) Trading Performance Indicators
OptimizeRx Corp (OPRX) is currently performing well based on its current performance indicators. A quick ratio of 2.57 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.05. Likewise, its price to free cash flow for the trailing twelve months is 30.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.74 in one year’s time.
Technical Analysis of OptimizeRx Corp (OPRX)
OptimizeRx Corp (NASDAQ: OPRX) saw its 5-day average volume 0.75 million, a positive change from its year-to-date volume of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 45.12%.
During the past 100 days, OptimizeRx Corp’s (OPRX) raw stochastic average was set at 91.94%, which indicates a significant increase from 85.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.11 in the past 14 days, which was higher than the 0.88 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.46, while its 200-day Moving Average is $8.40.
